TIL
Instil Bio Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$54.80M
P/E Ratio
—
EPS
$-10.70
Beta
2.03
52W High
$42.79
52W Low
$5.67
50-Day MA
$8.53
200-Day MA
$15.14
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Instil Bio Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. The company is headquartered in Dallas, Texas.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 138,000 |
| EBITDA | $-52.37M |
| Operating Margin | 0.00% |
| Return on Equity | -50.40% |
| Return on Assets | -14.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $16.79 |
| Price-to-Book | 0.48 |
| Price-to-Sales (TTM) | 54248.82 |
| EV/Revenue | 43213.95 |
| EV/EBITDA | 0.62 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $6.78M |
| Float | $3.23M |
| % Insiders | 6.29% |
| % Institutions | 65.98% |
Historical Volatility
HV 10-Day
32.75%
HV 20-Day
43.77%
HV 30-Day
45.03%
HV 60-Day
50.79%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($29.00 target)
1
Buy3
HoldData last updated: 4/29/2026